Asst Prof RadOnc @WinshipAtEmory #hncsm #lymsm @UF RadOnc | @UofR MD | @sunygeneseo BS Minimizing long-term effects of cancer. Tweets=mine

Atlanta, GA
A sincere appreciation and acknowledgment to the 440 patients, investigators, and institutions who participated on this Phase III randomized trial highlighting the ability of proton therapy (IMPT) to de-intensify treatment and improve survival @MDAndersonNews
Results from a study led by @SJFrankMD found a survival benefit for patients with oropharyngeal cancers treated with proton therapy than the patients receiving traditional radiation therapy. More on the findings, published today in @TheLancet: spr.ly/6014CDJfp #EndCancer
2
14
59
10,954
This is a fantastic technique that brings real relief to patients - it is critical knowledge for all radiation oncologists who take inpatient call as we certainly all get called about this patient population!
Celiac plexus RT can alleviate intractable, narcotic-refractory pain, but target volumes may not be intuitive. We use guidelines from @LawrenceYaacov paper (PMID 39029483) to show the contouring approach, step by step. Plus other treatment planning pearls. Great job, Peter Lee!
1
2
7
2,111
Had a great time this week with my @ASCO Leadership Development Program class!
ASCO LDP Class of 2025-26 takes a prom photo 📸. Thanks to our mentor @montypal who doubles as expert photographer!
1
3
14
7,003
James Bates retweeted
Excited to help bring CIRT back to the U.S. Still a long road ahead, but proud to be part of the journey. @MayoCancerCare @MayoRadOnc @LauraVallow
Today, Mayo Clinic opened the Duan Family Building, taking another step in our journey to introduce carbon ion therapy for patients in the Americas. This revolutionary treatment will enhance our ability to treat aggressive cancers. Learn more: mayocl.in/4mYTVme
1
5
44
1,759
Was a great session this morning! Honored to give a talk in this beautiful city!
Day 5 is here — the final day of #PTCOG63! We open with Plenary 07: Updates in Lymphoma Proton Therapy 🧬 Who benefits? – Youlia M. Kirova ⚙️ How to deliver it – James Bates 🔮 Future directions – Sara St. James Let’s finish strong! 💪 #ProtonTherapy #RadiationOncology
1
1
13
724
Potentially practice-changing evidence for proton therapy in the treatment of oropharynx cancer.
Practice-changing data from Dr. Steven Frank @SJFrankMD at #PTCOG63 on head & neck proton therapy. Level 1 evidence shows improved survival, reduced G-tube dependence, and favorable cost-effectiveness vs IMRT. A new standard is taking shape. @PTCOG_Official @MDAndersonNews
1
11
609
James Bates retweeted
This is the REAL problem with US Healthcare. Time to break them up.
24
121
446
47,191
James Bates retweeted
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study out on JCO buff.ly/4jeicCV This study investigated the incidence, risk factors, and outcomes of melanoma as a subsequent malignant neoplasm among childhood cancer survivors in the Childhood Cancer Survivor Study cohort. Among 25,716 participants, 177 melanomas developed in 160 survivors, with a 40-year cumulative incidence of 1.1%. Childhood cancer survivors had more than double the risk of developing invasive melanoma compared to the general population (SIR 2.0). Key risk factors included high-dose radiation (≥40 Gy), cyclophosphamide (≥20,000 mg/m²), and bleomycin exposure, all significantly associated with increased melanoma risk. Survivors who developed invasive melanoma faced over twice the risk of death (HR 2.4). These findings highlight the need for ongoing surveillance and risk management for melanoma in this population. @SethRotz @DrRebeccaHowel1 @JamesBatesMD
4
11
1,372
It was a great annual #HNCIG meeting. Thanks to everyone who participated either in Athens or online.
2
6
31
4,126
Very sad that I could not join in Athens - looks to be an incredible meeting and hope to be in-person at the next iteration!
The HNCIG currently holds its annual meeting in #Athens. With about 60 members attending in person and over 200 participants following the meeting online, it is a great achievement for the HNCIG. We have a lot of fruitful discussions here. Thanks for the great organisation!
4
424
Excited to speak about de-escalation in HPV+ oropharyngeal cancer and on late cardiac toxicity all in one meeting @somera_mx - very honored by the invite and the conference venue is truly breathtaking (Huatulco, Oaxaca)
4
416
An amazing step forward in a relatively challenging to treat disease space that hasn't seen much progress in a long time. Look forward to seeing more results from this!
7
920
98% PFS at 2 years in 70 Gy arm - will take really excellent selection tools to de-escalate with those results
‼️@sueyom presenting @NRGonc HN005 interim analysis @ASTRO_org #ASTRO24. Safe to say concurrent IO-RT (as of current field/delivery) is not beneficial across disease sites. But given all negative HN trials even for other drug studies thus far, where do we go from here? @imrtlee @xrtGenomics @seanmmcbride @IJROBP @yaoyu_md @DrJohndeAlmeida @xrtGenomics @JJCaudell @MFGensheimer @Qle_stanford @drlorenmell @JamesBatesMD @HenryParkMD @henson_md
2
1
10
1,283
Congrats @TopfHNS! Well-deserved
Thrilled to announce that I have received a K08 through the @theNCI to further investigate 3D scanning and augmented reality in surgical oncology. Thank you to @VanderbiltENT @VUMC_Cancer @ViseVanderbilt and primary mentor @EbenRosenthal for the support. Time to get to work!
3
476
Congrats to my friend @YG_TAO & GORTEC for this huge trial of IO in LA HNSCC Avelumab-cetuximab inferior to cisplatin CRT in fit patients but superior to cetuximab-RT for PFS in cisplatin ineligible population. #ESMO2024
1
28
58
6,522
Great resource! - always something we can do @WinshipAtEmory
🚨New Book on Low-Dose Radiation for Painful Musculoskeletal Conditions🚨 Free Download Now Available Over the past year, there has been a remarkable surge of interest in using low-dose radiotherapy to treat painful musculoskeletal conditions like osteoarthritis, plantar fasciitis, tendonitis, and bursitis. Many have inquired about how to initiate a program, secure institutional backing, leverage social media for promotion, and explore the supporting literature for these treatments. This interest inspired Dr. Richard Shaffer and me to author a book designed to assist radiation oncologists and administrators in launching such programs. The book will serve as an excellent supplement to a structured training program. ❇️ The book is now available. Click on the link below to download 👇 ❇️ All I request is for you to hit the repost button below so this can reach as many radiation oncologists as possible 👇 #radonc motivated-designer-9812.ck.p…
3
426
Great commentary and agree with @_katelynatkins - when treating the thorax, we have the data to move beyond mean heart dose
And great editorial commentary by @gwalls89 and @Al_McWilliam jacc.org/doi/10.1016/j.jacca… Thank you for the insightful discussion of our work and the state of the field! We are indeed “past the point of no return” for mean heart dose… @CSCancerCenter @CedarsSinai @SmidtHeart
3
407
Looking forward to this - will be a great part of @ASTRO_org #ASTRO24
You heard it once already, but here it is again. Get yourself to #ARROChella where we have 47 mentors lined up for you to meet! Job panels, leadership discussions, mentorship meet n greets... you name, it we've got it on Saturday, Sept 28! #ARRODayisSaturday
11
746